A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study
- 浏览0
Gynecologic Oncology
433-438页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



